An observational study to describe treatment patterns of patients with BRAFV600E mutant metastatic non-small cell lung cancer (OCTOPUS).
An observational study to describe treatment patterns of patients with BRAFV600E mutant metastatic non-small cell lung cancer (OCTOPUS).
An observational study describing diagnosis and treatment patterns in adults with metastatic non-small cell lung cancer with BRAF V600E mutation in clinical practice, to assess treatment effectiveness and quality of life.
Brief summary
Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer diagnoses. Approximately 1-2% of patients affected by a NSCLC have a specific genetic mutation called BRAFV600E mutation.
In a context of a lack of information, it would be useful for the future patients to provide an overview of diagnosis and treatment processes using data of patients already affected by this cancer.
Therefore, the purpose of this study is to identify treatment patterns given to patients with mutated BRAFV600E mNSCLC and to describe the efficacy of treatments and patients’ quality of life in routine practice.
Contact Us
Need more information, click on the button to have access to the contact form.
Access to Lay Protocol Synopsis
Un résumé du protocole rédigé en termes simples et décrivant les objectifs de l’étude vous est proposé